Invention Grant
- Patent Title: Anxiolytic deuterated compound and medical use thereof
-
Application No.: US16687538Application Date: 2019-11-18
-
Publication No.: US11358944B2Publication Date: 2022-06-14
- Inventor: Bohua Zhong , Jiajun Yang
- Applicant: BEIJING JUNKE HUAYUAN MED TECH CO., LTD.
- Applicant Address: CN Beijing
- Assignee: BEIJING JUNKE HUAYUAN MED TECH CO., LTD.
- Current Assignee: BEIJING JUNKE HUAYUAN MED TECH CO., LTD.
- Current Assignee Address: CN Beijing
- Agency: Novick, Kim & Lee, PLLC
- Agent Allen Xue
- Priority: CN201710355025.7 20170519
- Main IPC: C07D307/77
- IPC: C07D307/77 ; A61P25/22 ; A61K9/00

Abstract:
The present invention provides compounds as represented by structural formula (I). In formula (I), R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, and R14 are separately H or deuterium (D) independently. Moreover, at least one of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, and R14 must be D. Also provided is use of any of the compounds or its pharmaceutical composition in the preparation of a drug for treating an anxiety.
Public/Granted literature
- US20200095219A1 ANXIOLYTIC DEUTERATED COMPOUND AND MEDICAL USE THEREOF Public/Granted day:2020-03-26
Information query